Related Experiment Video
Updated: May 19, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Echocardiographic patterns in treatment-naïve HIV-positive patients in Lagos, south-west Nigeria
D A Olusegun-Joseph1, J N A Ajuluchukwu, C C Okany
1Department of Cardiology, Lagos University Teaching Hospital, Lagos, Nigeria. danielsangrt@gmail.com
Insights
HIV infection significantly increases the risk of cardiac abnormalities, including systolic and diastolic dysfunction, even in treatment-naïve patients. Early echocardiographic evaluation is recommended for HIV-infected individuals.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Imaging
Background:
- Cardiovascular abnormalities are frequently observed in individuals with HIV infection, often without apparent symptoms.
- Early detection of cardiac issues in HIV patients is crucial for timely intervention.
Purpose of the Study:
- To identify early cardiac abnormalities in treatment-naïve HIV-infected patients using echocardiography.
- To compare the prevalence of echocardiographic findings between HIV-infected individuals and a control group.
Main Methods:
- A cohort of 100 treatment-naïve HIV-infected patients and 50 age-, gender-, and BMI-matched controls were recruited.
- Both groups underwent clinical assessment and echocardiographic evaluation for cardiac abnormalities.
- CD4+ T-cell count was measured in all HIV-infected patients.
Main Results:
- Echocardiographic abnormalities were significantly more prevalent in HIV-infected patients (78%) compared to controls (16%).
- HIV-infected patients showed higher rates of systolic dysfunction (30% vs. 8%) and diastolic dysfunction (32% vs. 8%).
- Pericardial effusion (47%) and dilated cardiomyopathy (5%) were observed in HIV-infected patients, but not in controls.
Conclusions:
- Cardiac abnormalities are significantly more common in HIV-infected individuals than in the general population.
- Routine and periodic echocardiographic screening is recommended to detect early cardiac involvement in HIV disease.
- These findings highlight the importance of cardiovascular monitoring in HIV management.
Introduction:
Cardiovascular abnormalities are common in HIV-infected patients, although often clinically quiescent. This study sought to identify by echocardiography early abnormalities in treatment-naïve patients.
Methods:
One hundred patients and 50 controls with no known traditional risk factors for cardiovascular disease were recruited for the study. The cases and controls were matched for age, gender and body mass index. Both groups had clinical and echocardiographic evaluation for cardiac abnormalities, and CD4 count was measured in all patients.
Results:
The cases comprised 57 females (57.0%) and 43 males (43.0%), while the controls were 28 females (56.0%) and 22 males (44.0%) (χ(2) = 0.01; p = 0.913). The mean age of the cases was 33.2 ± 7.7, while that of the controls was 31.7 ± 9.7 (t = 1.02; p = 0.31). Echocardiographic abnormalities were significantly more common in the cases than the controls (78 vs 16%; p = 0.000), including systolic dysfunction (30 vs 8%; p = 0.024) and diastolic dysfunction (32 vs 8%; p = 0.002). Other abnormalities noted in the cases were pericardial effusion in 47% (χ(2) = 32.10; p = 0.000) and dilated cardiomyopathy in 5% (five); none of the controls had either complication. One patient each had aortic root dilatation, mitral valve prolapse and isolated right heart dilatation and dysfunction.
Conclusion:
Cardiac abnormalities are more common in HIV-infected people than in normal controls. A careful initial and periodic cardiac evaluation to detect early involvement of the heart in the HIV disease is recommended.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure IV: Classification and Diagnostic Evaluation
Myocarditis II: Clinical Features and Diagnostic Tests
Heart Failure III: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations

